{"id":"midodrine-hydrochloride-tablets","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Piloerection (goosebumps)"},{"rate":null,"effect":"Pruritus"},{"rate":null,"effect":"Supine hypertension"},{"rate":null,"effect":"Urinary retention"}]},"_chembl":{"chemblId":"CHEMBL1201212","moleculeType":"Small molecule","molecularWeight":"254.29"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Midodrine is a prodrug that is metabolized to desglymidodrine, its active metabolite, which selectively stimulates alpha-1 adrenergic receptors on arterioles and venules. This peripheral vasoconstriction increases both systolic and diastolic blood pressure, making it useful for treating conditions characterized by abnormally low blood pressure. The drug does not cross the blood-brain barrier significantly, limiting central nervous system effects.","oneSentence":"Midodrine is an alpha-1 adrenergic agonist that increases blood pressure by constricting blood vessels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:49:58.967Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Orthostatic hypotension"},{"name":"Symptomatic hypotension"}]},"trialDetails":[{"nctId":"NCT00262470","phase":"PHASE1, PHASE2","title":"Treatment of Orthostatic Intolerance","status":"ACTIVE_NOT_RECRUITING","sponsor":"Satish R. Raj","startDate":"1997-04","conditions":"Tachycardia, Chronic Orthostatic Intolerance","enrollment":150},{"nctId":"NCT02379156","phase":"PHASE4","title":"Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2015-04","conditions":"Tetraplegia, Hypothermia, Mild Cognitive Impairment","enrollment":30},{"nctId":"NCT05778838","phase":"PHASE2","title":"Midodrine Effect on the Mortality Rates in Septic Shock Patients","status":"COMPLETED","sponsor":"Noha Mansour","startDate":"2022-11-07","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT06405555","phase":"PHASE2, PHASE3","title":"Midodrine in Heart Failure With Reduced Ejection Fraction With Hypotension","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2024-08-01","conditions":"Heart Failure With Reduced Ejection Fraction, Hypotension, LV Dysfunction","enrollment":56},{"nctId":"NCT00648440","phase":"PHASE1","title":"Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2002-10","conditions":"Healthy","enrollment":36},{"nctId":"NCT00650364","phase":"PHASE1","title":"Fasting Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2002-08","conditions":"Healthy","enrollment":38},{"nctId":"NCT00650013","phase":"PHASE1","title":"Fed Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2002-07","conditions":"Healthy","enrollment":23},{"nctId":"NCT05803148","phase":"NA","title":"Treatment Strategy of Vasovagal Syncope","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-04-05","conditions":"Syncope, Vasovagal","enrollment":184},{"nctId":"NCT06213935","phase":"NA","title":"Preoperative Oral Midodrine Versus Intraoperative Intravenous Norepinephrine in Preventing Post-spinal Anesthesia Hypotension in Cesarean Section: A Prospective Double-blind Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Sohag University","startDate":"2024-02-01","conditions":"Post Spinal Anesthesia Hypotension","enrollment":90},{"nctId":"NCT05287100","phase":"NA","title":"To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-01-01","conditions":"Cirrhosis, Liver","enrollment":35},{"nctId":"NCT05548985","phase":"NA","title":"Midodrine for Prophylaxis Against Post Spinal Hypotension in Elderly Population","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-10-17","conditions":"Hypotension, Spinal Anesthesia, Elderly","enrollment":58},{"nctId":"NCT03431194","phase":"NA","title":"Midodrine is Effective in Management of Intradialytic Hypotension Among Critically-ill Patients With Acute Kidney Injury","status":"COMPLETED","sponsor":"Benha University","startDate":"2016-10-01","conditions":"Acute Kidney Injury","enrollment":80},{"nctId":"NCT05240391","phase":"PHASE3","title":"Midodrine Versus Albumin for Prevention of Paracentesis Induced Circulatory Disturbance","status":"COMPLETED","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2021-02-20","conditions":"Paracentesis-Induced Circulatory Dysfunction","enrollment":50},{"nctId":"NCT04455464","phase":"NA","title":"Effect of Midodrine on HVPG in Advanced Chronic Liver Disease","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-07-11","conditions":"Chronic Liver Disease","enrollment":60},{"nctId":"NCT05060523","phase":"NA","title":"To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2021-09-19","conditions":"Liver Cirrhosis","enrollment":220},{"nctId":"NCT01030874","phase":"NA","title":"Orthostatic Hypotension Treatment on Rehab Unit","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2011-10","conditions":"Orthostatic Hypotension, Falls","enrollment":356},{"nctId":"NCT04595942","phase":"PHASE3","title":"Midodrine and Fludrocortisone for Vasovagal Syncope","status":"UNKNOWN","sponsor":"Tehran Heart Center","startDate":"2020-11-19","conditions":"Syncope, Vasovagal","enrollment":1375},{"nctId":"NCT03129542","phase":"PHASE1","title":"Midodrine Hydrochloride in Early Sepsis","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-08-30","conditions":"Sepsis, Blood Pressure","enrollment":33},{"nctId":"NCT04396548","phase":"NA","title":"Midodrine for Improving Hemodynamics After Spinal Anesthesia","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2020-06-08","conditions":"Hypotension After Spinal Anesthesia","enrollment":70},{"nctId":"NCT04586790","phase":"PHASE2","title":"the Effect of Oral Vasopressors for Liberation From IV Vasopressors in Spinal Shock","status":"UNKNOWN","sponsor":"Ahmed talaat ahmed aly","startDate":"2020-10-15","conditions":"Spinal Shock","enrollment":90},{"nctId":"NCT04474262","phase":"NA","title":"Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-07-15","conditions":"Acute-On-Chronic Liver Failure","enrollment":150},{"nctId":"NCT01822535","phase":"PHASE4","title":"Body Temperature in Persons With Tetraplegia When Exposed to Cold","status":"COMPLETED","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2011-07","conditions":"Tetraplegia, Hypothermia, Mild Cognitive Impairment","enrollment":30},{"nctId":"NCT00108355","phase":"PHASE4","title":"Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2003-12","conditions":"Ascites, Cirrhosis","enrollment":29}],"_emaApprovals":[],"_faersSignals":[{"count":8,"reaction":"DRUG INEFFECTIVE"},{"count":3,"reaction":"DIZZINESS"},{"count":3,"reaction":"HEADACHE"},{"count":2,"reaction":"ASTHENIA"},{"count":2,"reaction":"DIARRHOEA"},{"count":2,"reaction":"DYSPNOEA"},{"count":2,"reaction":"DYSURIA"},{"count":2,"reaction":"HYPOTENSION"},{"count":2,"reaction":"INTENTIONAL PRODUCT MISUSE"},{"count":2,"reaction":"MALAISE"}],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Gutron"],"phase":"phase_3","status":"active","brandName":"Midodrine Hydrochloride Tablets","genericName":"Midodrine Hydrochloride Tablets","companyName":"Tehran Heart Center","companyId":"tehran-heart-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Midodrine Hydrochloride Tablets are a small molecule medication used to treat various conditions, including cirrhosis, liver disease, and acute kidney injury, as well as complications such as syncope and vasovagal syncope. The exact mechanism of action of Midodrine Hydrochloride Tablets is not specified, but they are used as an intervention in clinical trials to assess their efficacy in preventing complications related to these conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}